Sudeep Pharma Limited has initiated its IPO today, 21 November 2025. The public offering will be available to investors until 25 November 2025. This IPO consists of two components: a fresh issue of shares and an Offer for Sale (OFS), collectively valued at ₹895 crore. As of 11 am, the IPO recorded a 34% subscription according to provisional stock exchange data. The allotment basis is anticipated to be announced on 24 November, with the company’s shares expected to be listed on the BSE and NSE on 26 November 2025, subject to confirmation.
